Loading provider…
Loading provider…
Radiation Oncology Physician in Kansas City, KS
NPI: 1366683864Primary Practice Location
UNIVERSITY OF KANSAS HOSPITAL
4000 Cambridge St, Kansas City, KS
Primary Employer
Ku Radiation Therapy
kucancercenter.org
HQ Phone
Get Dr. Christopher's Phone Numberphone_androidMobile
Get Dr. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
CO State Medical License
2023 - 2027
MO State Medical License
2015 - 2026
NE State Medical License
2023 - 2026
KS State Medical License
2010 - 2025
NM State Medical License
2023 - 2023
DC State Medical License
2006 - 2010

American Board of Radiology
Radiation Oncology
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 2005
MedStar Health Georgetown University
Residency • Radiation Oncology
2006 - 2010
Icahn School of Medicine at Mount Sinai/Morningside/West
Internship • Internal Medicine
2005 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | G6002Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 163 | 1,298 |
| 2 | 77300Calculation of radiation therapy dose | 82 | 318 |
| 3 | 77427Radiation treatment management, 5 treatment sessions | 75 | 287 |
| 4 | 77334Design and construction of complex radiation treatment device | 87 | 210 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 151 | 194 |
Authors: Ryan Morse, Allen Chen, Rohit Ganju, Kiran Kakarala
Journal: Head Neck
Publication Date: 2019-03-11
Authors: Mallory, Matthew, Pokhrel, Damodar, Badkul, Rajeev, Jiang, Hongyu, Lominska, Christopher, Wang, Fen
Journal: J Appl Clin Med Phys
Publication Date: 2018-01-19
Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Authors: Sumit Sood, Xinglei Shen
Publication Date: 2016-01-07
Lead Sponsor: Matrix Biomed, Inc.
Intervention / Treatment: DRUG: Tempol, DRUG: Placebo Solution
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy
Lead Sponsor: Galera Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Low Dose GC4419: 30mg/day, DRUG: High Dose GC4419: 90mg/day